![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 5/0783 | (2010.01) |
C12M 1/04 | (2006.01) |
(11) | Number of the document | 3722415 |
(13) | Kind of document | T |
(96) | European patent application number | 20161276.9 |
Date of filing the European patent application | 2018-01-05 | |
(97) | Date of publication of the European application | 2020-10-14 |
(45) | Date of publication and mention of the grant of the patent | 2024-11-06 |
(46) | Date of publication of the claims translation | 2025-01-10 |
(30) | Number | Date | Country code |
201762478506 P | 2017-03-29 | US | |
201762539410 P | 2017-07-31 | US | |
201762548306 P | 2017-08-21 | US | |
201762554538 P | 2017-09-05 | US | |
201762559374 P | 2017-09-15 | US | |
201762567121 P | 2017-10-02 | US | |
201762577655 P | 2017-10-26 | US | |
201762582874 P | 2017-11-07 | US | |
201762596374 P | 2017-12-08 | US |
(72) |
WARDELL, Seth , US
BENDER, James , US
LOTZE, Michael, T. , US
|
(73) |
Iovance Biotherapeutics, Inc. ,
825 Industrial Road
Suite 400, San Carlos, CA 94070,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Navikus infiltruojančių limfocitų gamybos procesai ir jų panaudojimas imunoterapijoje |
PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY |
Payment date | Validity (years) | Amount | |
2024-12-17 | 8 | 185.00 EUR |
2026-01-05 |